Peripheral Vascular Devices Market Size, Share and Growth 2025-2033

Market Overview:

The Peripheral Vascular Devices Market is experiencing significant expansion, driven by Heightening Demand for Minimally Invasive Procedures, Technological Innovations in Vascular Devices, and Rising Prevalence of Peripheral Artery Disease (PAD). According to IMARC Group's latest research publication, "Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033",The global peripheral vascular devices market size reached USD 12.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Download a sample PDF of this report: https://www.imarcgroup.com/peripheral-vascular-devices-market/requestsample

Our Report Includes:

• Market Dynamics
• Market Trends and Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Peripheral Vascular Devices Market Industry:

• Heightening Demand for Minimally Invasive Procedures

The global peripheral vascular devices market is witnessing an escalating demand for minimally invasive procedures, primarily driven by the requirement for cost-effectiveness, minimized recovery times, and reduced complication rates. Devices like atherectomy systems, stents, and angioplasty balloons are rapidly gaining momentum due to their capability to treat peripheral artery diseases with reduced trauma to the patient. Moreover, as healthcare patients and providers are increasingly opting for such procedures, innovations in technology are rapidly growing to improve the accuracy and efficacy of such devices. In addition, this trend is boosting the market expansion, particularly as healthcare systems are currently focusing on patient-specific treatments and successful outcomes. As per industry reports, the minimally invasive surgery devices market is anticipated to expand from USD 14.06 billion in 2023 to USD 28.483 billion by the year 2032. This demonstrates the strong momentum behind minimally invasive approaches, which directly benefits the peripheral vascular devices sector as these techniques require specialized equipment designed for precision and safety.

• Technological Innovations in Vascular Devices

The peripheral vascular devices market is experiencing constant technological advancements that are significantly steering global market expansion. Innovations such as enhanced imaging techniques, drug-coated balloons, and bioresorbable stents are improving the efficacy of treatments for peripheral vascular diseases. According to a research article published in the journal Cardiovascular Interventions in May 2023, drug-coated balloons (DCBs) attained a 5-year freedom from reintervention procedures of 58% for in-stent restenosis, a condition associated with peripheral vascular diseases. Moreover, such advancements facilitate more accurate interventions, enhance patient outcomes, and lower the requirement for repeat procedures. In addition, the increasing incorporation of digital health solutions, such as data analytics and remote monitoring, is enabling better management of chronic vascular disorders. Furthermore, as manufacturers are heavily investing in research and development projects to bring leading-edge solutions to the market, the overall need for upgraded peripheral vascular devices is stably escalating.

• Rising Prevalence of Peripheral Artery Disease (PAD)

The amplifying prevalence of peripheral artery disease (PAD) is a crucial driver of the global market. With an elevation in aging population and the heightening incidents of risk factors such as smoking, diabetes, and hypertension, PAD cases are gradually becoming more prevalent globally. According to the International Diabetes Federation, the number of individuals suffering with diabetes will elevate to 643 million by 2030 and 783 million by the year 2045. Moreover, this accelerating patient pool is bolstering the demand for efficient vascular devices to treat as well as manage the condition. In addition, as awareness of PAD is notably fueling worldwide among both patients and healthcare providers, early diagnosis and intervention are also surging. Resultantly, there is a proliferating market for angioplasty balloons, stents, and various other devices developed to mitigate arterial blockages and enhance circulation, substantially contributing to the peripheral vascular devices market growth.

Key Trends in the Peripheral Vascular Devices Market:

• Innovations in Minimally Invasive Procedures and Amplifying Prevalence of Cardiovascular Disorders

The market growth is significantly propelled by ongoing innovations in minimally invasive procedures and amplifying prevalence of cardiovascular disorders. Moreover, demand for atherectomy devices, stents, and angioplasty balloons is heightening as healthcare providers emphasize on enhancing patient outcomes, driving substantial market expansion across medical industry. Peripheral vascular disease (PVD) is a circulatory condition caused due to the narrowing, blockage, or spasms in the blood vessels located outside the heart and brain. Such occurrences reduce the blood flow through the vessels, resulting in weakness, pain, gangrene, hair loss on the legs, numbness, and muscle heaviness. A notable development occurred in April 2024, when Abbott announced the receival of FDA approval for an innovative, first-of-its-kind Esprit BTK Everolimus Eluting Resorbable Scaffold System, a dissolvable stent specially designed for below-the-knee chronic limb-threatening ischemia disease, an acute form of peripheral artery disease.

• Enhanced Product Approvals and Clinical Trials

The peripheral vascular devices market is witnessing significant momentum through strategic product approvals and clinical trials that validate the efficacy and safety of innovative vascular solutions. In May 2024, BD Life Sciences announced the commencement of a clinical trial for its self-expanding vascular covered stent, designed for peripheral arterial disease and coated with fluoropolymer. This advancement highlights the industry's commitment to developing next-generation devices that offer improved clinical outcomes and procedural efficiency. Furthermore, regulatory approvals from major health authorities such as the FDA are accelerating market penetration and providing healthcare professionals with access to state-of-the-art treatment options. The increasing number of product launches by key market players, combined with favorable reimbursement policies, is creating a conducive environment for market expansion and adoption of advanced peripheral vascular devices across healthcare facilities globally.

• Rising Healthcare Expenditure and Research & Development Activities

The peripheral vascular devices market is benefiting from significant growth in the healthcare industry, rising expenditure capacities of consumers, and extensive research and development (R&D) activities. Moreover, the widespread adoption of atherectomy devices owing to the increasing prevalence of atherosclerosis, obesity, and lifestyle-related disorders is positively influencing the market growth. Healthcare systems worldwide are allocating substantial budgets toward advancing vascular care, recognizing the critical importance of effective treatment solutions for peripheral vascular diseases. The continuous investment in R&D by leading manufacturers is yielding breakthrough innovations such as bio-absorbable stents, advanced catheter technologies, and sophisticated imaging systems that enhance procedural precision. Additionally, the expansion of healthcare infrastructure in emerging markets, coupled with increasing patient awareness and physician training programs, is further supporting market growth across all major geographic regions.

We explore the factors propelling the peripheral vascular devices market growth, including technological advancements, consumer behaviors, and regulatory changes.

Leading Companies Operating in the Global Peripheral Vascular Devices Market Industry:

• Abbott Laboratories
• B. Braun SE
• Boston Scientific Corporation
• Cordis
• iVascular S.L.U.
• Medtronic plc
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• W. L. Gore & Associates, Inc.

Peripheral Vascular Devices Market Report Segmentation:

Breakup by Device Type:

• Peripheral Vascular Stents
• Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
• Peripheral Transluminal Angioplasty (PTA) Guidewires
• Atherectomy Devices
• Embolic Protection Devices
• Inferior Vena Cava Filters
• Others

Peripheral vascular stents exhibited a clear dominance in the market due to their widespread utilization across various vascular interventions, effectiveness in treating arterial blockages, versatility in different anatomical locations, ability to provide immediate structural support to compromised vessels, growing adoption in minimally invasive procedures, and superior clinical outcomes in managing peripheral artery disease.

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Care Centers
• Specialty Clinics
• Others

Hospitals and clinics exhibited a clear dominance in the market due to their advanced infrastructure, specialized medical staff, comprehensive facilities that support a wide range of vascular interventions, availability of sophisticated diagnostic and treatment equipment, established protocols for managing complex peripheral vascular conditions, higher patient volume for vascular procedures, and preference for performing critical interventions in controlled hospital environments.

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America dominated the global market due to the rising incidence of cardiovascular diseases, growing geriatric population, strong presence of industry players in the region, better healthcare infrastructure, high awareness among people and healthcare industry stakeholders about available technologies, favorable reimbursement policies, substantial healthcare expenditure, advanced research and development activities, and high concentration of market players particularly in the United States.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-201-971-6302